A Chinese medicine composition for treating osteoarthritis and its preparation method
Through the use of traditional Chinese medicine compositions such as Astragalus and Angelica, significant therapeutic effects have been achieved for the mechanisms of Qi deficiency, blood stasis and collateral stasis in osteoarthritis, and the adverse reactions and insufficient efficacy of existing treatment methods have been solved, and the problems of adverse reactions and insufficient efficacy of existing treatment methods have been provided. A safe and reliable treatment plan.
Patent Information
- Application Number
- CN202310628122.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-31
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2043-05-31
AI Technical Summary
The treatment of osteoarthritis has the adverse reactions of painkiller abuse, disorderly mixed treatment of multiple therapies and surgical treatment, and the long-term poor efficacy. The effect of traditional Chinese medicine such as Xijinbi Decoction is limited by cyst bile in the treatment of osteoarthritis. Characteristics of the disease.
According to the pathogenesis of qi deficiency, blood stasis and collateral numbness of osteoarthritis, Chinese medicine compositions such as Astragalus, Angelica sinensis, Sichuan acupuncture, turmeric, Duhuo, Red Peony, Binfeng, Mulberry Parasitology, Dilong, Licorice, etc. are used to promote Qi and activate blood circulation by invigorating Qi and promoting blood circulation , the effect of unblocking the collaterals and removing numbness is prepared into decoctions, granules, pills, tablets or capsules for the treatment of osteoarthritis.
It significantly improves the symptoms of osteoarthritis, has significant efficacy and no serious adverse reactions, is safe and reliable, and simplifies the preparation process and improves the efficacy of traditional Chinese medicine compositions.
Smart Images

Figure BDA0004257603890000112 
Figure BDA0004257603890000121 
Figure BDA0004257603890000123
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of Chinese medicine compositions, and more specifically, to a Chinese medicine composition for treating osteoarthritis and a preparation method thereof. Background Art
[0002] Osteoarthritis (OA) is a chronic joint disease characterized by degeneration, destruction and proliferation of articular cartilage and subchondral bone. Epidemiological studies have shown that OA affects one-third of the elderly population over 65 years old, and the disability rate after the disease is as high as 53%. Due to the increase in risk factors such as obesity and population aging, the prevalence of OA will continue to rise, seriously affecting the safety and quality of life of patients, and has become a global public health problem that needs to be solved urgently.
[0003] At present, the clinical treatment of OA has been accompanied by the abuse of analgesics, disordered mixing of multiple therapies, adverse reactions to surgical treatment, and poor long-term efficacy. Therefore, it is necessary to seek other safe and effective treatment methods. Traditional Chinese medicine has unique advantages in the prevention and treatment of OA because it adheres to the guiding principles of holistic concepts and syndrome differentiation and treatment. For example, the Qubi Decoction in the "Yang Family Collection of Prescriptions" is mainly used to treat post-injury wind-cold arthralgia and has a certain therapeutic effect on osteoarthritis.
[0004] However, since osteoarthritis is difficult to cure and is prone to recurrence, the disease has the characteristics of "long-term numbness entering the meridians", which causes blockage of the meridians and affects the therapeutic effect of Qubi Decoction on osteoarthritis. Summary of the invention
[0005] Based on the above technical problems existing in the prior art, the present invention provides a Chinese medicine composition that has the effects of invigorating qi and activating blood circulation, unblocking collaterals and removing numbness, and can effectively treat osteoarthritis according to the core pathogenesis of osteoarthritis, namely qi deficiency, blood stasis, and obstruction of collateral vessels.
[0006] In order to achieve the above object, the technical solution of the present invention is as follows:
[0007] A traditional Chinese medicine composition for treating osteoarthritis, wherein the active ingredients are prepared from the following raw materials in weight proportion: 18-22 parts of astragalus, 8-12 parts of angelica, 5-8 parts of cyathula, 5-8 parts of turmeric, 5-8 parts of angelica root, 5-8 parts of angelica root, 5-8 parts of radix pubescens, 5-8 parts of red peony root, 8-12 parts of siler, 4-7 parts of parasitic plant, 8-12 parts of earthworm and 1-4 parts of liquorice.
[0008] In some embodiments, the active ingredients of the traditional Chinese medicine composition are prepared from the following raw materials in the following weight ratio: 20 parts of Astragalus, 10 parts of Angelica, 6 parts of Cyathula, 6 parts of Curcuma, 6 parts of Angelica dahurica, 6 parts of Radix Angelicae Pubescentis, 6 parts of Red Peony Root, 10 parts of Saposhnikovia, 6 parts of Viscum album, 8 parts of Pheretima, and 3 parts of Licorice.
[0009] In some embodiments, the traditional Chinese medicine composition is a preparation prepared by adding pharmaceutically acceptable excipients to the powder of the raw material drug, the water or organic solvent extract of the raw material drug in the weight ratio as the active ingredient.
[0010] In some embodiments, the Chinese medicine composition is a decoction, granules, pills, tablets or capsules.
[0011] In some embodiments, the method for preparing the Chinese medicine composition comprises the following steps:
[0012] Astragalus, angelica, Cyathula, turmeric, angelica pubescens, red peony root, siler, mistletoe, earthworm and liquorice are weighed according to the raw material ratio, directly powdered, or extracted with water and / or organic solvent, and then added with pharmaceutically acceptable excipients or auxiliary ingredients to make the preparation.
[0013] In some embodiments, the method for preparing the Chinese medicine composition comprises the following steps:
[0014] S1. According to the raw material ratio, weigh astragalus, angelica, cyathula, turmeric, angelica pubescens, red peony root, saposhnikovia divaricata, mistletoe, earthworm and liquorice, add 10-15 times the weight of the medicinal materials in distilled water and decoct twice, each decoction time is 1-1.5h, and filter and combine the filtrate;
[0015] S2, the filtrate is concentrated to 90-95℃ with a relative density of 1:1.08-1.10, cooled to room temperature, and 95% ethanol is added to adjust the alcohol precipitation concentration to 70%;
[0016] S3, let stand at 4℃ for more than 24h, filter, concentrate the filtrate to recover ethanol, and concentrate into an extract with a density of 1:1.25-1.30 at 50-60℃;
[0017] S4, further drying the extract to obtain a dry extract;
[0018] S5. Add pharmaceutically acceptable excipients to prepare a preparation.
[0019] In some embodiments, step S5 is specifically to prepare granules by fluidized bed granulation.
[0020] In some implementations, step S5 is specifically:
[0021] 1) grinding the extract dry extract into fine powder, passing through a 100-mesh sieve to obtain dry extract powder; placing the dry extract powder and lactose in a fluidizing chamber of a fluidized bed, and adjusting the air volume until the material boils;
[0022] 2) After the material is preheated, spraying is started. When the temperature of the material reaches 40°C, the atomizer is turned on, the atomizer pressure is adjusted to 0.1MPa, and then the binder is sprayed into the fluidizing chamber for granulation; wherein the binder is HPMC with a concentration of 5%;
[0023] 3) Adjust the fan speed to 1700 rpm, the inlet air temperature to 65°C, and the peristaltic pump feed speed to 4→6→8 Hz;
[0024] 4) After the granules are formed, they need to be dried with hot air at 50°C. After 0.5h, the granules are taken out and weighed, and the granules are passed through No. 1 sieve and No. 5 sieve respectively. Finally, the granules that can pass through No. 1 sieve but not No. 5 sieve are collected and sorted, and the granules are packaged.
[0025] The pharmacological effects of the present invention are as follows:
[0026] Astragalus: sweet in taste, slightly warm in nature; enters the spleen and lung meridians. Strengthens the spleen and replenishes the middle, replenishes qi and raises yang, consolidates the exterior and stops sweating, promotes diuresis and reduces swelling, removes toxins and discharges pus, and heals sores and promotes tissue regeneration. Indications: spleen qi deficiency syndrome, lung qi deficiency syndrome, qi deficiency and spontaneous sweating syndrome, qi and blood deficiency, sores that are difficult to heal or heal, or sores that are difficult to heal after a long time.
[0027] Angelica: bitter, pungent, slightly warm; enters the liver, heart, and spleen meridians. It nourishes blood and activates blood circulation, regulates menstruation and relieves pain, and moistens the intestines and promotes bowel movements. It is used for blood deficiency and sallow complexion, dizziness and palpitations, cold and asthenia abdominal pain, dry intestines and constipation, rheumatic arthralgia, injuries from falls, and carbuncle sores.
[0028] Rhizoma Cynoglossi: sweet, slightly bitter, neutral in nature. It enters the liver and kidney meridians, can remove blood stasis, dredge the meridians, open the joints, promote diuresis and relieve stranguria. It is mainly used to treat blood stasis, amenorrhea, abdominal masses, joint pain, traumatic injuries, hematuria, and postpartum retention of placenta.
[0029] Turmeric: bitter and pungent, warm in nature; enters the spleen and liver meridians. It promotes blood circulation and qi circulation, relieves pain from menstruation. It is mainly used to treat chest and flank pain, swelling and pain from falls, rheumatic pain, amenorrhea, and abdominal masses.
[0030] Duhuo: sweet in taste, slightly warm in nature; enters the liver, kidney and bladder meridians. It has the functions of dispelling wind and dampness, relieving numbness and relieving pain. It is used for wind-cold-dampness arthralgia, pain in the waist and knees, and headache caused by the hidden wind of Shaoyin.
[0031] Red peony root: bitter, slightly cold; enters the liver meridian. Clears heat and cools blood, dissipates blood stasis and relieves pain. Used for heat entering the blood, fever toxicity causing rash, vomiting blood and bleeding, red and swollen eyes, liver depression and flank pain, amenorrhea and dysmenorrhea, abdominal pain caused by urticaria, injuries from falls, carbuncle, swelling and ulcers, etc.
[0032] Saposhnikovia root: spicy, sweet, warm in nature. It has the effects of dispelling sweat, expelling wind and removing dampness, and is mainly used to treat colds, headaches, fever, anhidrosis, joint pain, rheumatic pain, limb cramps, tetanus, etc.
[0033] Mulberry parasite: bitter, sweet, neutral in nature; enters the liver and kidney meridians. It has the functions of nourishing the liver and kidneys, strengthening the tendons and bones, removing rheumatism, and lowering blood pressure. It is used for rheumatic pain, soreness of the waist and knees, weakness of the tendons and bones, and hypertension.
[0034] Earthworm: salty in taste, cold in nature; enters the liver, spleen, and bladder meridians. Clears away heat and calms the nerves, dredges the meridians, relieves asthma, and promotes urination. Indications: high fever, coma, epilepsy, convulsions, joint pain, limb numbness, hemiplegia, diuresis, edema, hypertension, etc.
[0035] Licorice: sweet, neutral in nature; enters the heart, lung, spleen, and stomach meridians. It nourishes the spleen and replenishes qi, clears away heat and detoxifies, removes phlegm and relieves cough, relieves pain, and harmonizes the properties of medicines. It is used for spleen and stomach weakness, fatigue, palpitations and shortness of breath, cough with sputum, abdominal pain, cramps and pain in the limbs, carbuncles, sores, and relieves drug toxicity and potency.
[0036] Compared with the prior art, the present invention has the following beneficial effects:
[0037] The Chinese medicine composition for treating osteoarthritis provided by the present invention is based on the core pathogenesis of osteoarthritis of qi deficiency, blood stasis and obstruction of collateral vessels, and on the understanding of the pathogenesis of osteoarthritis of "qi deficiency, blood stasis and collateral obstruction". It uses astragalus, angelica, cyathula, turmeric, angelica pubescens, red peony root, saposhnikovia divaricata, mistletoe, earthworm and liquorice as components, and follows the medication principle of "monarch, minister, assistant and envoy" of traditional Chinese medicine. Astragalus is used heavily in the prescription to generate blood and promote blood circulation, and to invigorate qi to promote blood circulation; angelica is pungent and warms the body, and promotes blood circulation to relieve pain. The two are both monarch drugs; turmeric and red peony root promote qi and dispel Blood stasis and collateral dredging, Achyranthes bidentata promotes blood circulation to promote the circulation of limbs and tendons, and can lead medicine to lead blood into the knee, which are all ministerial drugs; this syndrome is due to the guest of wind, cold and dampness in the limbs and joints, and the qi and blood are not smooth, so it is assisted by Radix Angelicae Pubescentis and Radix Saposhnikoviae to dispel wind and dampness, among which, Radix Angelicae Pubescentis is good at descending, to dispel the wind, cold and dampness between the tendons and bones of the lower limbs, and Radix Saposhnikoviae dispels the wind of the whole body and overcomes dampness; long-term arthralgia enters the collateral, causing the obstruction of the collaterals, and is assisted by Pheretima to dredge the collaterals and relieve pain, and arthralgia syndrome is seen with liver and kidney deficiency over time, and is assisted by Herba Mori Parasiticae to tonify the liver and kidney and strengthen the tendons and bones; Radix Glycyrrhizae invigorates qi and relieves pain, and harmonizes various drugs, which is the guiding drug. All drugs are used together, and the meridians can be dredge, rheumatism can be eliminated, and qi and blood can be harmonious, then the pain of arthralgia disappears. The Chinese medicine composition of the present invention is used to treat osteoarthritis, and has remarkable efficacy and no serious adverse reactions occur, and is safe and reliable.
[0038] In addition, the preparation method of the present invention is simple and has stable process parameters, which can enable each component to achieve a synergistic technical effect and improve the efficacy of the traditional Chinese medicine composition. DETAILED DESCRIPTION
[0039] Many specific details are set forth in the following description to facilitate a full understanding of the present invention. However, the present invention can be implemented in many other ways than those described herein, and those skilled in the art can make similar modifications without violating the connotation of the present invention, so the present invention is not limited to the specific implementation disclosed below.
[0040] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention herein are only for the purpose of describing specific embodiments and are not intended to limit the present invention.
[0041] The present invention provides a traditional Chinese medicine composition for treating osteoarthritis, which is prepared from the following raw materials in weight ratio:
[0042] 18-22 parts of Astragalus, 8-12 parts of Angelica, 5-8 parts of Cyathula, 5-8 parts of Curcuma, 5-8 parts of Angelicae Pubescentis, 5-8 parts of Paeonia lactiflora, 8-12 parts of Saposhnikovia divaricata, 4-7 parts of Viscum album, 8-12 parts of Pheretima, and 1-4 parts of Licorice.
[0043] Preferably, the Chinese medicine composition is prepared from the following raw materials in the following weight ratio: 20 parts of Astragalus, 10 parts of Angelica, 6 parts of Cyathula, 6 parts of Curcuma, 6 parts of Angelica Pubescentis, 6 parts of Paeonia lactiflora, 10 parts of Saposhnikovia divaricata, 6 parts of Viscum album, 8 parts of Pheretima, and 3 parts of Licorice.
[0044] The present invention also provides a method for preparing the above-mentioned Chinese medicine composition for treating osteoarthritis, which method comprises the following steps:
[0045] Astragalus, angelica, Cyathula, turmeric, angelica pubescens, red peony root, siler, mistletoe, earthworm and liquorice are weighed according to the raw material ratio, directly powdered, or extracted with water and / or organic solvent, and then added with pharmaceutically acceptable excipients or auxiliary ingredients to make the preparation.
[0046] Furthermore, the preparation method of the Chinese medicine composition comprises the following steps:
[0047] S1. According to the raw material ratio, weigh astragalus, angelica, cyathula, turmeric, angelica pubescens, red peony root, saposhnikovia divaricata, mistletoe, earthworm and liquorice, add 10-15 times the weight of the medicinal materials in distilled water and decoct twice, each decoction time is 1-1.5h, and filter and combine the filtrate;
[0048] S2, the filtrate is concentrated to 90-95℃ with a relative density of 1:1.08-1.10, cooled to room temperature, and 95% ethanol is added to adjust the alcohol precipitation concentration to 70%;
[0049] S3, let stand at 4℃ for more than 24h, filter, concentrate the filtrate to recover ethanol, and concentrate into an extract with a density of 1:1.25-1.30 at 50-60℃;
[0050] S4, further drying the extract to obtain a dry extract;
[0051] S5. Add pharmaceutically acceptable excipients to prepare a preparation.
[0052] More specifically, step S5 includes the following steps:
[0053] 1) grinding the extract dry extract into fine powder, passing through a 100-mesh sieve to obtain dry extract powder; placing the dry extract powder and lactose in a fluidizing chamber of a fluidized bed, and adjusting the air volume until the material boils;
[0054] 2) After the material is preheated, spraying is started. When the temperature of the material reaches 40°C, the atomizer is turned on, the atomizer pressure is adjusted to 0.1MPa, and then the binder is sprayed into the fluidizing chamber for granulation; wherein the binder is HPMC with a concentration of 5%;
[0055] 3) Adjust the fan speed to 1700 rpm, the inlet air temperature to 65°C, and the peristaltic pump feed speed to 4→6→8 Hz;
[0056] 4) After the granules are formed, they need to be dried with hot air at 50°C. After 0.5 h, the granules are taken out and weighed, and the granules are passed through No. 1 sieve and No. 5 sieve respectively. Finally, the granules that can pass through No. 1 sieve but not No. 5 sieve are collected and sorted, and the granules are packaged to obtain granules.
[0057] The specific implementation methods provided by the present invention are described in detail below in conjunction with specific examples.
[0058] Example 1
[0059] A Chinese medicine composition for treating osteoarthritis, wherein the active ingredients are prepared from the following raw materials in parts by weight:
[0060] Astragalus 20g, Angelica 10g, Cyathula 6g, Curcuma 6g, Angelica pubescens 6g, Paeonia lactiflora 6g, Saposhnikovia 10g, Viscum album 6g, Pheretima terrestris 8g, Licorice root 3g;
[0061] The preparation method of the Chinese medicine composition of this embodiment comprises the following steps:
[0062] S1. According to the raw material ratio, weigh astragalus, angelica, cyathula, turmeric, angelica pubescens, red peony root, saposhnikovia divaricata, mistletoe, earthworm and liquorice, add distilled water 10 times the weight of the medicinal materials and decoct twice, each decoction time is 1 hour, filter and combine the filtrate;
[0063] S2, the filtrate is concentrated to 90-95℃ with a relative density of 1:1.08-1.10, cooled to room temperature, and 95% ethanol is added to adjust the alcohol precipitation concentration to 70%;
[0064] S3, let stand at 4℃ for 24h, filter, concentrate the filtrate to recover ethanol, and concentrate into an extract with a density of 1:1.25-1.30 at 50-60℃;
[0065] S4, further drying the extract to obtain a dry extract;
[0066] S5, grinding the extract dry extract into fine powder, passing through a 100-mesh sieve to obtain dry extract powder; placing the dry extract powder and lactose in a fluidizing chamber of a fluidized bed, and adjusting the air volume until the material boils;
[0067] S6. After the material is preheated, spraying is started. When the temperature of the material reaches 40°C, the atomizer is turned on, the atomizer pressure is adjusted to 0.1MPa, and then the binder is sprayed into the fluidizing chamber for granulation; wherein the binder is HPMC with a concentration of 5%;
[0068] S7, adjust the fan speed to 1700rpm, the inlet air temperature to 65℃, and the peristaltic pump feed speed to 4→6→8Hz;
[0069] S8. After the granules are formed, they need to be dried with hot air at 50°C. After 0.5h, the granules are taken out and weighed. The granules are passed through No. 1 sieve and No. 5 sieve respectively. Finally, the granules that can pass through No. 1 sieve but not No. 5 sieve are collected and sorted, and the granules are packaged to obtain granules.
[0070] Example 2
[0071] A Chinese medicine composition for treating osteoarthritis, wherein the active ingredients are prepared from the following raw materials in parts by weight:
[0072] Astragalus 20g, Angelica 11g, Cyathula 6g, Curcuma 5g, Angelica pubescens 6g, Paeonia lactiflora 6g, Saposhnikovia 10g, Viscum album 6g, Pheretima terrestris 8g, Licorice root 3g;
[0073] The preparation method of the Chinese medicine composition of this embodiment is the same as that of Example 1.
[0074] Example 3
[0075] A Chinese medicine composition for treating osteoarthritis, wherein the active ingredients are prepared from the following raw materials in parts by weight:
[0076] Astragalus 20g, Angelica 10g, Cyathula 6g, Curcuma 6g, Angelica pubescens 6g, Paeonia lactiflora 6g, Saposhnikovia 11g, Viscum album 6g, Pheretima lumbini 10g, Licorice root 2g;
[0077] The preparation method of the Chinese medicine composition of this embodiment is the same as that of Example 1.
[0078] Example 4
[0079] A Chinese medicine composition for treating osteoarthritis, wherein the active ingredients are prepared from the following raw materials in parts by weight:
[0080] Astragalus 20g, Angelica 11g, Cyathula officinalis 7g, Curcuma longa 5g, Angelica pubescens 6g, Paeonia lactiflora 6g, Saposhnikovia divaricata 10g, Viscum album 7g, Pheretima lumbini 8g, Licorice root 2g;
[0081] The preparation method of the Chinese medicine composition of this embodiment is the same as that of Example 1.
[0082] Pharmacological experiments
[0083] In order to further evaluate the efficacy of the Chinese medicine composition of the present application, the granules of Example 1 were taken as an example to conduct pharmacological experiments, as follows
[0084] 1. Animal Experiments
[0085] 1. Experimental Animals
[0086] Healthy female New Zealand white rabbits, normal grade, weighing 2kg-2.5kg, were purchased from the Experimental Animal Research Institute of Guizhou University of Traditional Chinese Medicine (Animal Certificate No.: NO.10662350000023), and were allowed to drink water and eat freely.
[0087] 2. Animal Grouping and Establishment of Rabbit Osteoarthritis Model
[0088] Thirty-five New Zealand white rabbits were randomly divided into five groups, each with seven rabbits, namely, sham operation group, model group, sample group, Chinese medicine control group, and positive drug control group. After one week of adaptive feeding, except for the sham operation group, the osteoarthritis model was established by the internal meniscus instability method in the remaining experimental animals, specifically:
[0089] After the experimental animals were anesthetized successfully with sodium pentobarbital, they were disinfected and a longitudinal incision of about 0.5-1 cm was made on the skin of the anterior medial side of the knee joint. The skin, fascia, and patellar ligament were removed in turn to expose the medial meniscus and the medial meniscus tibial ligament; the medial meniscus tibial ligament was cut; the medial meniscus was explored to be free, and the model was successfully established; the incision was sutured. After surgery, the joints were closely observed for bleeding, swelling, infection, etc. Three days after surgery, 400,000 U of penicillin were injected daily. In the sham operation group, only the medial meniscus tibial ligament was exposed, and the ligament was not cut. The rest of the steps were basically the same as the modeling operation.
[0090] 3. Method of administration
[0091] Six weeks after modeling, medication began. The specific method of administration was as follows:
[0092] Sample group: 4 g crude drug / kg granules (i.e., granules prepared in Example) were gavaged once a day for 4 consecutive weeks;
[0093] The Chinese medicine control group was given the Qunbi decoction (composition: 9g Qianghuo, 9g Turmeric, 9g Angelica, 9g Astragalus, 9g Red Peony, 9g Saposhnikovia, 3g Licorice) in Yang's Family Prescriptions by gavage, with 4g crude drug / kg of decoction, once a day for 4 consecutive weeks;
[0094] Positive drug control group: 5 mg / kg celecoxib was administered orally once a day for 4 consecutive weeks;
[0095] Sham operation group: gavage with the same volume of normal saline daily;
[0096] Model group: The same volume of normal saline was gavaged daily.
[0097] 4. Observation indicators
[0098] The effects of each group on body weight, serum inflammatory factors and articular cartilage of osteoarthritis model rabbits were observed respectively.
[0099] After 4 weeks of intragastric administration, about 5 mL of blood was collected from the heart using a blood collection tube without any additives, and the blood was allowed to stand for 2 hours at room temperature. After the blood coagulated, it was centrifuged (4000r / min, 5min). The supernatant obtained was serum, which was aspirated and dispensed into EP tubes and stored at -80°C. The expression of inflammatory factors was monitored by ELISA. After anesthesia and sacrifice, articular cartilage tissue was obtained. After gross observation of the knee articular cartilage, the knee joint was cut off, and the femur was cut 1 cm away from the articular surface of the femoral condyle. The soft tissue at the distal epiphysis of the femur was removed and fixed in a 4% paraformaldehyde solution, stained with safranin fast green, and scored by Mankin.
[0100] 5. Experimental Results
[0101] (1) Effects of each group on the body weight of rabbits with osteoarthritis model
[0102] After 4 weeks of administration, the body weight of the sample group was significantly heavier than that of the Chinese medicine control group and the positive drug control group (p < 0.05), as shown in Table 1.
[0103] Table 1 Comparison of body weight of rabbits in each group before and after administration ( Kg)
[0104]
[0105]
[0106] Note: Compared with the sham operation group, * p<0.05; compared with the model group, # p<0.05; compared with the Chinese medicine control group, ▲ p<0.05; compared with the positive drug group, & p<0.05.
[0107] (2) Effects of samples on serum inflammatory factors in rabbit models
[0108] ELISA was used to detect the expression levels of IL-6 and TNF-α in the blood of each group. The results showed that compared with the sham operation group, the expression levels of serum IL-6 and TNF-α in the other four groups were significantly increased (p < 0.05); compared with the model group, the IL-6 and TNF-α levels in the serum of the sample group, the Chinese medicine control group, and the positive drug group were significantly reduced (p < 0.05); compared with the Chinese medicine control group and the positive drug group, the expression levels of IL-6 and TNF-α in the serum of the sample group were reduced (p < 0.05), as shown in Table 2.
[0109] Table 2 Comparison of serum IL-6 and TNF-α levels in rabbits of each group ( umol / L)
[0110]
[0111] Note: Compared with the sham operation group, * p<0.05; compared with the model group, # p<0.05; compared with the Chinese medicine control group, ▲ p<0.05; compared with the positive drug group, & p<0.05.
[0112] (3) Safranin Fast Green staining Mankin scoring results
[0113] Compared with the sham operation group, the Mankin scores of the other four groups were significantly increased (p < 0.05); compared with the model group, the Mankin scores of the sample group, the Chinese medicine control group, and the positive drug group were significantly decreased (p < 0.05); compared with the Chinese medicine control group, the Mankin score of the sample group was significantly decreased (p < 0.05); as shown in Table 3.
[0114] Table 3 Comparison of Mankin scores of rabbit knee joints in each group ( point)
[0115]
[0116] Note: Compared with the sham operation group, * p<0.05; compared with the model group, # p<0.05; compared with the Chinese medicine control group, ▲ p<0.05.
[0117] 2. Clinical Research
[0118] 1. Grouping
[0119] Treatment group: granules prepared in Example 1, taken with water, 10 g each time, 3 times a day;
[0120] Chinese medicine control group: Qubi decoction from Yang's Family Prescriptions, composed of 9g of Notopterygium wilfordii, 9g of Curcuma longa, 9g of Angelica sinensis, 9g of Astragalus membranaceus, 9g of Red Peony Root, 9g of Saposhnikovia divaricata, and 3g of Licorice root; one dose per day, warm in the morning and evening;
[0121] Positive drug group: 60 mg of etoricoxib tablets, once a day.
[0122] 2. Randomization of Patients
[0123] Due to the large amount of data, 90 patients were randomly selected from 500 patients with osteoarthritis in the orthopedic outpatient clinic and divided into a treatment group, a Chinese medicine control group, and a positive drug group at a ratio of 1:1:1 according to a random number table, with 30 cases in each group; among them: there were 10 males and 20 females in the treatment group, with an age of 62.3±4.7 years old; there were 10 males and 20 females in the Chinese medicine control group, with an age of 63.1±4.9 years old; there were 11 males and 19 females in the positive drug group, with an age of 61.3±5.6 years old.
[0124] There was no significant difference in the general data of the three groups of patients before treatment (P>0.05), and they were comparable.
[0125] 3. Observation indicators and efficacy evaluation
[0126] After 2 weeks of medication, the efficacy and incidence of adverse reactions were observed in the three groups.
[0127] 4. Results
[0128] (1) Comparison of VAS pain scores: There was no significant difference in VAS scores among the three groups before treatment (P>0.05); the VAS scores of the three groups were significantly reduced after treatment (P<0.05); compared with the Chinese medicine control group, the VAS score of the treatment group was significantly reduced (P<0.05); as shown in Table 4.
[0129] Table 4 Comparison of VAS scores among the three groups ( point)
[0130]
[0131] Note: Compared with before treatment, * P<0.05; compared with the Chinese medicine control group, #p<0.05.
[0132] (2) Comparison of WOMAC scores: Compared with before treatment, the WOMAC scores of the three groups were significantly reduced after treatment (P < 0.05). Compared with the three groups after treatment, the WOMAC scores of the treatment group were lower than those of the Chinese medicine control group and the positive drug group, and the difference was statistically significant (P < 0.05); the details are shown in Table 5.
[0133] Table 5 Comparison of WOMAC scores between the two groups ( point)
[0134]
[0135] Note: Compared with before treatment, * P<0.05, compared with the Chinese medicine control group, #p<0.05; compared with the positive drug group, ▲p<0.05.
[0136] (3) Comparison of efficacy: The effective rate of the disease efficacy in the treatment group was better than that in the Chinese medicine control group and the positive drug group, and the difference was statistically significant (P < 0.05); the details are shown in Table 6.
[0137] Table 6 Comparison of therapeutic effects among three groups of diseases
[0138]
[0139]
[0140] Note: Compared with the Chinese medicine control group, *p<0.05; compared with the positive drug group, #p<0.05.
[0141] (4) Safety comparison: Two patients in the positive drug group experienced mild stomach discomfort after taking the drug, which improved after rest. No adverse reactions occurred in the other two groups, indicating that the treatment of the present invention is relatively safe.
[0142] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0143] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. A Chinese medicine composition for treating osteoarthritis, characterized in that: The active ingredients are prepared from the following raw materials in the following weight ratio: 18-22 parts of astragalus, 8-12 parts of angelica, 5-8 parts of cyathula, 5-8 parts of turmeric, 5-8 parts of angelica root, 5-8 parts of angelica pubescens, 5-8 parts of red peony root, 8-12 parts of siler, 4-7 parts of mistletoe, 8-12 parts of earthworm and 1-4 parts of liquorice.
2. The Chinese medicine composition for treating osteoarthritis according to claim 1, characterized in that: The active ingredients of the traditional Chinese medicine composition are prepared from the following raw materials in the following weight ratio: 20 parts of astragalus, 10 parts of angelica, 6 parts of cyathula, 6 parts of turmeric, 6 parts of angelica root, 6 parts of angelica pubescens, 6 parts of red peony root, 10 parts of siler, 6 parts of mistletoe, 8 parts of earthworm and 3 parts of liquorice.
3. The Chinese medicine composition for treating osteoarthritis according to claim 1, characterized in that: The Chinese medicine composition is a preparation prepared by adding pharmaceutically acceptable excipients to the powder of the raw material medicine and the water or organic solvent extract of the raw material medicine in the weight ratio as active ingredients.
4. The Chinese medicine composition for treating osteoarthritis according to claim 1, characterized in that: The Chinese medicine composition is in the form of decoction, granules, pills, tablets or capsules.
5. The method for preparing the Chinese medicine composition for treating osteoarthritis according to any one of claims 1 to 4, characterized in that: The following steps are involved: Astragalus, angelica, Cyathula, turmeric, angelica pubescens, red peony root, siler, mistletoe, earthworm and liquorice are weighed according to the raw material ratio, directly powdered, or extracted with water and / or organic solvent, and then added with pharmaceutically acceptable excipients or auxiliary ingredients to make the preparation.
6. The method for preparing the Chinese medicine composition for treating osteoarthritis according to claim 5, characterized in that: The following steps are involved: S1. According to the raw material ratio, weigh astragalus, angelica, cyathula, turmeric, angelica pubescens, red peony root, saposhnikovia divaricata, mistletoe, earthworm and liquorice, add 10-15 times the weight of the medicinal materials in distilled water and decoct twice, each decoction time is 1-1.5h, and filter and combine the filtrate; S2, the filtrate is concentrated to 90-95℃ with a relative density of 1:1.08-1.10, cooled to room temperature, and 95% ethanol is added to adjust the alcohol precipitation concentration to 70%; S3, let stand at 4℃ for more than 24h, filter, concentrate the filtrate to recover ethanol, and concentrate into an extract with a density of 1:1.25-1.30 at 50-60℃; S4, further drying the extract to obtain a dry extract; S5. Add pharmaceutically acceptable excipients to prepare a preparation.
7. The method for preparing the Chinese medicine composition for treating osteoarthritis according to claim 6, characterized in that: Step S5 specifically comprises preparing granules by fluidized bed granulation.
8. The method for preparing the Chinese medicine composition for treating osteoarthritis according to claim 7, characterized in that: Step S5 specifically includes the following steps: 1) grinding the extract dry extract into fine powder, passing through a 100-mesh sieve to obtain dry extract powder; placing the dry extract powder and lactose in a fluidizing chamber of a fluidized bed, and adjusting the air volume until the material boils; 2) After the material is preheated, spraying is started. When the temperature of the material reaches 40°C, the atomizer is turned on, the atomizer pressure is adjusted to 0.1MPa, and then the binder is sprayed into the fluidizing chamber for granulation; wherein the binder is HPMC with a concentration of 5%; 3) Adjust the fan speed to 1700 rpm, the inlet air temperature to 65°C, and the peristaltic pump feed speed to 4→6→8 Hz; 4) After the granules are formed, they need to be dried with hot air at 50°C. After 0.5h, the granules are taken out and weighed, and the granules are passed through No. 1 sieve and No. 5 sieve respectively. Finally, the granules that can pass through No. 1 sieve but not No. 5 sieve are collected and sorted, and the granules are packaged.
Citation Information
Patent Citations
Traditional Chinese medicine for treating rheumatoid arthritis
CN101979074A
Ten-element traditional Chinese medicine decoction tablet for treatment of periomethritis
CN103845685A
